BT3 Intrinsic Valuation and Fundamental Analysis - Lineage Cell Therapeutics Inc

	Lineage Cell Therapeutics Inc F:BT3	US
A	Adani Ports and Special Economic Zone Ltd BSE:532921	IN
	Fisher & Paykel Healthcare Corporation Ltd F:FPLB	NZ

Intrinsic Value

The intrinsic value for Lineage Cell Therapeutics Inc (BT3) under the Base Case is 1.277 EUR. Compared with the current market price of 1.114 EUR, the stock appears Undervalued by 13% .

DCF Value

€1.5

Multiples-Based Value

€1.054

DCF Value

€1.5

Multiples-Based Value

€1.054

DCF suggests undervaluation, while multiples suggest overvaluation.

Why combine DCF with multiples? What is Intrinsic Value?

BT3 Intrinsic Value

Undervaluation 13%

Intrinsic Value

Price €1.114

L

Bear Case

Base Case

Bull Case

Track Buy Zone

20% below Intrinsic Value €1.02

Get notified when the price drops into your buy zone

Intrinsic Value €1.28

Current Price €1.11

Margin of Safety 20% €1.02

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Loading...

What is Valuation History?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Lineage Cell Therapeutics Inc.

Explain Valuation